<?xml version="1.0" encoding="UTF-8"?>
<TEI xml:space="preserve" xmlns="http://www.tei-c.org/ns/1.0" 
xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" 
xsi:schemaLocation="http://www.tei-c.org/ns/1.0 /opt/grobid/grobid-home/schemas/xsd/Grobid.xsd"
 xmlns:xlink="http://www.w3.org/1999/xlink">
	<teiHeader xml:lang="en">
		<fileDesc>
			<titleStmt>
				<title level="a" type="main"></title>
			</titleStmt>
			<publicationStmt>
				<publisher/>
				<availability status="unknown"><licence/></availability>
			</publicationStmt>
			<sourceDesc>
				<biblStruct>
					<analytic>
						<author>
							<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Ruben</forename><forename type="middle">D</forename><surname>Vromans</surname></persName>
							<email>r.d.vromans@uvt.nl</email>
						</author>
						<author>
							<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Mies</forename><forename type="middle">C</forename><surname>Van Eenbergen</surname></persName>
							<email>m.vaneenbergen@iknl.nl</email>
						</author>
						<author>
							<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Steffen</forename><forename type="middle">C</forename><surname>Pauws</surname></persName>
							<email>s.c.pauws@uvt.nl</email>
						</author>
						<author>
							<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">G</forename><surname>Geleijnse</surname></persName>
							<email>g.geleijnse@iknl.nl</email>
						</author>
						<author>
							<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Henk</forename><forename type="middle">G</forename><surname>Van Der Poel</surname></persName>
						</author>
						<author>
							<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Emiel</forename><forename type="middle">J</forename><surname>Krahmer</surname></persName>
							<email>e.j.krahmer@uvt.nl</email>
						</author>
						<author>
							<affiliation key="aff0">
								<orgName type="department">Department of Communication and Cognition</orgName>
								<orgName type="institution">Tilburg University</orgName>
								<address>
									<settlement>Tilburg</settlement>
									<country key="NL">The Netherlands</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff1">
								<orgName type="laboratory">Tilburg center for Cognition and Communication</orgName>
								<orgName type="institution">Tilburg University</orgName>
								<address>
									<settlement>Tilburg</settlement>
									<country key="NL">The Netherlands</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff2">
								<orgName type="department">Department of Research</orgName>
								<orgName type="institution">Netherlands Comprehensive Cancer Organization (IKNL)</orgName>
								<address>
									<settlement>Utrecht</settlement>
									<country key="NL">The Netherlands</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff3">
								<orgName type="department">Chronic Disease Management</orgName>
								<orgName type="institution">Philips Research</orgName>
								<address>
									<settlement>Eindhoven</settlement>
									<country key="NL">The Netherlands</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff4">
								<orgName type="department">Department of Urology</orgName>
								<orgName type="institution" key="instit1">The Netherlands Cancer Institute</orgName>
								<orgName type="institution" key="instit2">Antoni van Leeuwenhoek Hospital</orgName>
								<address>
									<settlement>Amsterdam</settlement>
									<country key="NL">The Netherlands</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff5">
								<orgName type="department">Division of Psychosocial Research &amp; Epidemiology</orgName>
								<orgName type="institution">The Netherlands Cancer Institute</orgName>
								<address>
									<settlement>Amsterdam</settlement>
									<country key="NL">The Netherlands</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff6">
								<orgName type="department">Department of Medical and Clinical Psychology</orgName>
								<orgName type="institution">Tilburg University</orgName>
								<address>
									<settlement>Tilburg</settlement>
									<country key="NL">The Netherlands</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff7">
								<orgName type="department">Department of Communication and Cognition</orgName>
								<orgName type="institution">Tilburg University</orgName>
								<address>
									<postCode>5035 AB</postCode>
									<settlement>Tilburg</settlement>
									<country key="NL">The Netherlands</country>
								</address>
							</affiliation>
						</author>
					</analytic>
					<monogr>
						<imprint>
							<date/>
						</imprint>
					</monogr>
				</biblStruct>
			</sourceDesc>
		</fileDesc>
		<encodingDesc>
			<appInfo>
				<application version="0.6.1" ident="GROBID" when="2025-06-29T11:49+0000">
					<desc>GROBID - A machine learning software for extracting information from scholarly documents</desc>
					<ref target="https://github.com/kermitt2/grobid"/>
				</application>
			</appInfo>
		</encodingDesc>
		<profileDesc>
			<textClass>
				<keywords>
					<term>Communicative Aspects of Decision Aids for Localized Prostate Cancer Treatment -A Systematic Review Decision Support Techniques</term>
					<term>Decision Aids</term>
					<term>Health Communication</term>
					<term>Patient Education</term>
					<term>Prostatic Neoplasms</term>
					<term>Shared Decision-Making</term>
				</keywords>
			</textClass>
			<abstract>
				<p>Context: Despite increasing interest in the development and use of decision aids (DAs) for patients with localized prostate cancer (LPC), little attention has been paid to communicative aspects (CAs) of such tools. Objective: To identify DAs for LPC treatment, and review these tools for various CAs. Materials and methods: DAs were identified through both published literature (MEDLINE, Embase, CINAHL, CENTRAL, and PsycINFO; 1990-2018) and online sources, in compliance with the Preferred Reporting Items for Systematic Review and Meta-Analyses (PRISMA) guidelines. Identified DAs were reviewed for the International Patient Decision Aid Standards (IPDAS) criteria, and analyzed on CAs, including information presentation, personalization, interaction, information control, accessibility, suitability, and source of information. Nineteen DAs were identified. Results: IPDAS scores varied greatly among DAs. Crucially, substantial variations in use of CAs by DAs were identified: (1) few DAs used visual aids to communicate statistical information, (2) none were personalized in terms of outcome probabilities or mode of communication, (3) a minority used interactive methods to elicit patients&apos; values and preferences, (4) most included biased cross-tables to compare treatment options, and (5) issues were observed in suitability and accessibility that could hinder implementation in clinical practice. Conclusions: Our review suggests that DAs for LPC treatment could be further improved by adding CAs such as personalized outcome predictions, and interaction methods to the DAs. Clinicians who are using or developing such tools might therefore consider these CAs in order to enhance patient participation in treatment decision making.</p>
			</abstract>
		</profileDesc>
	</teiHeader>
	<text xml:lang="en">
		<body>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="1.">Introduction</head><p>Men newly diagnosed with localized prostate cancer (LPC) are facing difficult decisions regarding treatment. They need to choose from a range of treatment options (e.g., surgery, external beam radiotherapy, brachytherapy, or active surveillance) 1 , which have equivalent survival outcomes but differ in the risk of adverse outcomes <ref type="bibr" target="#b2">2,</ref><ref type="bibr" target="#b3">3</ref> . This scenario calls for shared decision making (SDM), a three-step process by which clinician and patient (i) discuss treatment options, (ii) compare risks and benefits, and (iii) make sure that the final decision is preference-based <ref type="bibr" target="#b4">4,</ref><ref type="bibr" target="#b5">5</ref> . SDM may involve decision aids (DAs), which are tools (e.g., booklets or websites) that provide balanced information about options and the associated risks and benefits, and help patients to clarify values and preferences and how to communicate these with their clinician <ref type="bibr" target="#b6">6</ref> . Today, there are hundreds of patient DAs in various health domains, ranging from cancer to heart disease <ref type="bibr" target="#b7">7</ref> . Even though DAs have potential <ref type="bibr" target="#b7">7</ref> , systematic reviews have shown variability in the effects of DAs for LPC treatment on decisional outcomes (including decisional conflict and knowledge) and treatment choice <ref type="bibr" target="#b8">[8]</ref><ref type="bibr" target="#b9">[9]</ref><ref type="bibr" target="#b10">[10]</ref> .</p><p>An explanation for the inconsistent effects may be that DAs have been developed and implemented without taking into account the communicative process in which SDM occurs <ref type="bibr" target="#b11">11</ref> . Classic models of this process assume that communication requires a sender and a receiver who are exchanging information through a certain channel <ref type="bibr" target="#b12">12</ref> . In addition, this communication process can involve aspects such as feedback (i.e., the receiver's response to a message) or noise (i.e., anything not intended by the sender). Seen from this perspective, SDM is a similar two-way communicative process in which both clinician and patient convey and receive messages through available channels in order to reach a decision regarding treatment <ref type="bibr" target="#b13">13</ref> . Indeed, communication models of SDM also acknowledge the role of DAs in this communication process <ref type="bibr" target="#b14">14</ref> . Therefore, it is important to look into communicative aspects (CAs) of DAs that could potentially influence elements of the communication process between clinician and patient.</p><p>These CAs include, first of all, the channels through which DAs communicate to patients, which can either be unimodal (e.g., using text or pictures alone) or multimodal (e.g., using text with pictures or audiovisual information) <ref type="bibr" target="#b15">[15]</ref><ref type="bibr" target="#b16">[16]</ref><ref type="bibr" target="#b17">[17]</ref> . The latter is particularly important for complex topics such as explaining surgical procedures or statistical information <ref type="bibr" target="#b18">18,</ref><ref type="bibr" target="#b19">19</ref> . Another aspect is that DAs can signal information based on interactions with the patient, for instance, by clarifying values or preferences, or by providing personalized information for a specific receiver based on input of that receiver <ref type="bibr" target="#b20">20,</ref><ref type="bibr" target="#b21">21</ref> .</p><p>Moreover, information provided by DAs may also be less suitable or accessible because of various forms of noise such as complex language use (e.g., jargon), or biased presentations of risks and benefits of treatments <ref type="bibr" target="#b22">22</ref> . Despite the importance of communication characteristics of DAs, no research exists that has systematically reviewed such patient tools for LPC treatment from a communication point of view.</p><p>When reviewing the quality of DAs, researchers often make use of a standardized quality checklist developed by the International Patient Decision Aids Standards (IPDAS) Collaboration <ref type="bibr" target="#b6">6,</ref><ref type="bibr" target="#b23">23</ref> . Nevertheless, even though the IPDAS checklist is seen as the golden standard for developing and evaluating DAs <ref type="bibr" target="#b24">24</ref> , it is also important to consider other aspects of the communication process that are not covered by the IPDAS. Until now, only one systematic review by Adsul and colleagues has reviewed the quality of DAs for LPC treatment by using additional items related to implementation (e.g., health literacy) <ref type="bibr" target="#b25">25</ref> .</p><p>Although their results lead to a global understanding of the variability in characteristics and quality of DAs, more in-depth analyses of some CAs are still required to get a more complete understanding of DAs as a communicative tool in the context of SDM.</p><p>The objectives of this review are to (1) systematically identify currently available DAs for LPC treatment through both academic and online sources, (2) review these tools for IPDAS criteria and, crucially, (3) assess them on a range of aspects deemed to be important for the communication process. By doing so, this review will both update and extend previous work <ref type="bibr" target="#b25">25</ref> , and will also take a closer look at various CAs of DAs.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="2.">Materials and Methods</head><p>This systematic review was reported in compliance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines 26 .</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="2.1">Data sources and search strategy</head><p>A systematic search of published literature and online sources was performed in order to identify and obtain DAs for LPC treatment. To identify DAs through published literature, we searched the following databases: MEDLINE (via PubMed), EMBASE, Cochrane Library, The Cumulative Index to Nursing and Allied Health Literature (CINAHL), and PsycINFO. Databases were searched from 1990 to 2018. Reference lists and author names were searched to identify additional publications that met the eligibility criteria. The search strategy was developed in collaboration with an experienced research librarian, and included a combination of keywords, synonyms, and MeSH headings relating to the concepts of LPC, DAs, SDM, and treatments (Appendix A). To identify DAs through online sources, we searched two international web repositories: The Ottowa Decision Aid Library Inventory and The International Database for Support in Medical Choices (Med-Decs).</p><p>An additional Internet search using Google TM was conducted in both Dutch and English for which the first 100 hits were analyzed.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="2.2">Study and decision aid eligibility</head><p>Studies were included if the research was reported in a scientific journal (peer-reviewed), published between 1990 and 2018, and written in English or Dutch. Study types eligible for inclusion were (protocols of) randomized controlled trials or (quasi) experimental studies that addressed the impact of DAs as intervention on a variety of decisional outcomes or treatment choice. In addition, studies that described the developmental and/or evaluation of DAs (e.g., developmental studies, evaluation/usability testing studies, and observational studies) were also included. Target audiences of studies included newly diagnosed patients with LPC facing treatment decision making, as well as patients with early-stage or low/intermediate-risk prostate cancer. DAs developed for men with advanced prostate cancer or Prostate-Specific Antigen screening were excluded. DA formats included paper-based (e.g., hardcopy booklets, or pamphlets), web-based (e.g., Internet websites), computer-based (e.g., computer programs, CD-ROMs) or videobased (e.g., video-tape or DVD). However, DAs in the format of phone calls, online support groups, interviews, nomograms or audiotapes were excluded, since such formats could not be analyzed. Finally, only DAs that were (publicly) accessible, referred to at least two treatments, and were written in English or Dutch were included.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="2.3">Study and decision aid selection</head><p>A first reviewer (RV) screened all retrieved articles for relevance based on title and abstract for initial eligibility, after which a second reviewer (GG) screened a package of 10% of the articles that consisted of a mix of included/excluded studies judged by the first reviewer (RV). The overall kappa score for inter-rate agreement was strong (κ = .90) <ref type="bibr" target="#b27">27</ref> .</p><p>Afterwards, disagreements were resolved through discussion or adjudication by a third person. Subsequently, two reviewers (RV, ME) independently evaluated the articles that passed the previous screening phase based on the eligibility criteria using a pre-defined criteria form (κ = .96), and disagreements were resolved through discussion and consensus between the two reviewers. Once a study had been included, one reviewer (RV) contacted the study authors for obtaining permission to request and review a copy of the DA (or to get full access to the DA).</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="2.4">Assessment of decision aids</head><p>The assessment of the identified DAs consisted of two parts. DAs were first reviewed for the IPDAS criteria, after which they were critically analyzed on a range of CAs. For both checklists, we carried out extensive pilot testing and discussions in order to make sure that every reviewer interpreted the items in the same way. Six teams of two coders each were responsible for reviewing one sixth of the DAs. Thus, each DA was independently assessed by two coders. Inter-rate agreements (κ) achieved by the teams ranged from .80 to .82 for the IPDAS checklist, and from .81 to .93 for the assessment of CAs. and 'no' (coded as 1 and 0 respectively). For each DA, the number of IPDAS items met was converted to percentages of the total number of items.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="2.4.2">Communicative aspects.</head><p>Given that there was no validated CA checklist available for DAs, we developed a new checklist. We first selected aspects from the communication model by Shannon and Weaver 12 in order to determine the following seven CAs: (i) information presentation (derived from channel), (ii) personalization (derived from message), (iii) interaction (derived from interaction), (iv) information control (derived from feedback), (v) accessibility (derived from noise), (vi) suitability (derived from noise), and (vii) source of information (derived from source of information). We then generated a list of 76 items, which were partly derived from an existing checklist <ref type="bibr" target="#b25">25</ref> , and were supplemented with items from reviews about (communicative) features of DAs <ref type="bibr" target="#b28">28,</ref><ref type="bibr" target="#b29">29</ref> and from the Suitability Assessment of Materials checklist <ref type="bibr" target="#b30">30</ref> . These items were subsequently divided into the seven CAs (Appendix C).</p><p>Information presentation contained items that focused on the channels used to communicate different types of information (e.g., verbal descriptors, numbers, or visual aids), but also on how treatment comparison was realized. Personalization comprised items related to how the information was tailored towards the patient (e.g., tailoring outcome probabilities or content). Interaction contained items that concerned how the interaction between the DA and the patient was established (e.g., interaction methods used to clarify personal values and preferences), for which a distinction was made between passive (e.g., methods that did not require active participation) and active (e.g., exercises that did require active participation) interaction methods. Items relating to information control dealt with how the patient had control over access to information (e.g., option to only view information of interest), but also how feedback was established (e.g., summary of a patient's preferences). Accessibility involved items that focused on how accessible the DA was (e.g., whether the DA required login information), and suitability focused on how suitable the content of the DA was (e.g., presence of irrelevant illustrations). Finally, source of information yielded items that concerned whether and how the source of probability information was given (e.g., information about patients involved in the reported trials).</p><p>Response options for each item were 'yes' and 'no' (coded as 1 and 0 respectively; seven items needed to be recoded). Since six items were only applicable to web-based DA, the total number of items for paper-based DAs was 70, and for web-based 76. For each DA, the number of CA items was converted to percentages of the total number of items. Note that a higher CA score does not necessarily indicate a higher quality DA; it merely suggests that more items from the CA checklist were taken into account. Nine DAs were obtained through online sources, and ten DAs through published literature and had 1 or 2 associated studies <ref type="bibr" target="#b31">[31]</ref><ref type="bibr" target="#b32">[32]</ref><ref type="bibr" target="#b33">[33]</ref><ref type="bibr" target="#b34">[34]</ref><ref type="bibr" target="#b35">[35]</ref><ref type="bibr" target="#b36">[36]</ref><ref type="bibr" target="#b37">[37]</ref><ref type="bibr" target="#b38">[38]</ref><ref type="bibr" target="#b39">[39]</ref><ref type="bibr" target="#b40">[40]</ref><ref type="bibr" target="#b41">[41]</ref><ref type="bibr" target="#b42">[42]</ref><ref type="bibr" target="#b43">[43]</ref><ref type="bibr" target="#b44">[44]</ref><ref type="bibr" target="#b45">[45]</ref><ref type="bibr" target="#b46">[46]</ref> , of which 7 were randomized controlled trials, 6 evaluation and/or usability studies, 2 protocols of randomized controlled trials, and 1 cross-sectional study. Methods and narrative descriptions of each study are shown in <ref type="table" target="#tab_1">Table 2</ref>.    Patients were given a DA and were interviewed before and after the decision-making consultation.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="3.">Results</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="3.1">Search results and general characteristics</head><p>The use of a DA led to more active involvement in treatment decision making and more information exchange between clinician and patient. Also, the DA had a positive impact on the decision making process, and improved the quality of the consultation. Note. DA = Decision aid; LPC = Localized prostate cancer; N.A. = Not applicable; RCT = Randomized controlled trial.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="3.2">IPDAS</head><p>A summary of the results on the IPDAS checklist can be found in Appendix items were below 50%). <ref type="figure" target="#fig_5">Figure 2</ref> shows the IPDAS scores for each DAs, and <ref type="figure" target="#fig_6">Figure 3a</ref> displays the variation of the IPDAS scores for each dimension.  </p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="3.3">Communicative aspects</head><p>A full summary of the results on the CA checklist can be found in Appendix C. The percentage of CA items met by the DAs ranged from 32% to 64% (M = 51%, SD = 9%). <ref type="figure" target="#fig_5">Figure 2</ref> shows the CA scores for each DA, and <ref type="figure" target="#fig_6">Figure 3b</ref> displays the variation of the CA scores for each aspect.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="3.3.1">Information presentation</head><p>All 19 DAs used absolute verbal expressions, of which 15 (79%) also used relative verbal expressions; 18 (95%) also used numerical information to convey probabilities, of which natural frequencies were most common (16; 84%) followed by absolute risks (13; 68%), percentages (10; 53%), and relative risks and number needed to treat (both 1; 5%). A minority (6; 32%) used visual aids, of which icon arrays were most frequently used (5; </p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="3.3.2">Personalization</head><p>The majority of the DAs (17; 89%) were tailored toward the specific stage of the prostate cancer. Tailoring towards the type of treatment, specific populations, or other prostate cancer-related factors (e.g., PSA value) only occurred in 3 (16%), 1 (5%), and 3 DAs (16%) respectively. Seven of the aids allowed (37%) patients to tailor the content of the DA. However, none of the DAs allowed patients to view probabilities based on their own situation, or to tailor information to patients' own preference for the mode of information presentation.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="3.3.3">Interaction</head><p>Of </p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="3.3.4">Information control</head><p>Eleven DAs (58%) allowed patients to only receive information that they wanted to read.</p><p>All except for 1 DA (95%) provided a step-by-step way to move through the DA, and 16</p><p>(84%) provided patients the opportunity to read more about a specific topic of interest.</p><p>The majority (16; 84%) included the option to search for keywords by means of the "ctrlf" function or a search bar.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="3.3.5">Accessibility and suitability</head><p>In terms of accessibility, a total of 15 DAs (79%) were freely available on the web, and 5 </p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="3.3.6">Source of information</head><p>Of the 19 DAs, most included probabilities for treatment side effects and/or quality of life (15; 79%) followed by mortality rate (12; 63%) incidence rate (9; 47%) treatment after active surveillance (6; 32%) survival rate (5; 26%) progression of cancer (4; 21%) and co-morbidity (1; 5%). Only 6 DAs (32%) reported the original source of the data, of which half provided detailed information about the patients included in the data(sets) and the period of data collection.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="4.">Discussion</head><p>In this systematic review, we identified 19 DAs for LPC treatment decision making, and reviewed them for IPDAS criteria and their usage of various CAs. Consistent with previous reviews <ref type="bibr" target="#b8">[8]</ref><ref type="bibr" target="#b9">[9]</ref><ref type="bibr" target="#b10">[10]</ref><ref type="bibr" target="#b25">25</ref> , adherence to the IPDAS checklist varied substantially across DAs. Many did not adhere to good practice guidance on the presentation of outcome probabilities associated with treatment options, and also lacked substantial information regarding the development process and readability levels of the aids. More importantly, a novel finding of this review was that the use of CAs also varied substantially across DAs. Here, we will discuss some major CA shortcomings found in the DAs, andbased on insights from communication researchprovide recommendations and best practices for clinicians who are involved in the development or use of DA in their clinical practice (for an overview, see <ref type="table" target="#tab_4">Table 3</ref>).</p><p>First of all, only a minority of the DAs used visual aids or other graphical methods to convey statistical information. However, given that this kind of information is often difficult to process and understand for many patients <ref type="bibr" target="#b18">18</ref> , various guidelines and best practices have been developed over the years how to communicate this through multiple channels <ref type="bibr" target="#b47">47,</ref><ref type="bibr" target="#b48">48</ref> . Moreover, content-related information (e.g., LPC, procedures of treatments) was most of the time explained unimodally rather than multimodally.</p><p>However, there is substantial evidence that the latter form often leads to better information recall <ref type="bibr" target="#b15">[15]</ref><ref type="bibr" target="#b16">[16]</ref><ref type="bibr" target="#b17">[17]</ref> , especially for people with lower health numeracy and health literacy skills <ref type="bibr" target="#b49">49</ref> .</p><p>Therefore, future DA developments should consider the possible communication channels (and their combination) through which different pieces of information can be explained to patients.</p><p>Another finding was that all DAs were generic and lacked personalization, particularly in terms of outcome probabilities (e.g., option to view statistics based on each patient's medical history) and mode of delivery (e.g., option to adjust the presentation modality). However, insights from health communication research suggest that individualized information is more likely to be considered as personally relevant (and hence, to be read) compared to generic and static information <ref type="bibr" target="#b20">20,</ref><ref type="bibr" target="#b21">21</ref> This in-depth processing of information can lead to higher levels of engagement, which potentially encourages patients to actively participate in SDM <ref type="bibr" target="#b50">50</ref> . Recent technological developments in data science and artificial intelligence offer promise for the generation of individualized risks and benefits of treatment options, and future studies should determine whether this personalized approach of DAs would also lead to improvements in LPC patients' understanding of risks <ref type="bibr" target="#b51">51,</ref><ref type="bibr" target="#b52">52</ref> . This review further reveals some other communicative issues that could potentially hinder the successful implementation of the DAs in clinical practice. For instance, the majority of the aids did not specify the original source of statistical information, or did not mention anything about the characteristics of the patients involved in the clinical trials.</p><p>However, this information could be helpful to patients to better understand how to apply the probabilities to their own situation <ref type="bibr" target="#b54">54</ref> . Furthermore, not all DAs were up-to-date and freely available to patients, some required login information to get full access, and most were quite lengthy in terms of size, which limits their potential usage. Therefore, we recommend clinicians who make use of DAs in their daily clinical practice to be aware of the suitability and accessibility of their tools for their patients. In addition, clinicians who  </p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Information presentation</head><p>Probability information was often communicated verbally (e.g., high chance of..") or numerically (e.g., "10% chance of..) but less visually (e.g., icon arrays).</p><p>Consider the possible communication channels through which different pieces of information can be explained to patients.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Personalization</head><p>Probability information of side effects of associated treatment options were generic and based on average statistics.</p><p>Make use of recent developments in artificial intelligence for determining individualized outcome probabilities based on patient data.</p><p>The mode of delivery was typically fixed (e.g., only text) and could not be personalized based on patients' preferences.</p><p>Consider the individual differences in information processing by patients, and how to personalize the mode of delivery of the DAs.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Interaction</head><p>Most side-by-side displays of the pros and cons of treatment options were biased and unbalanced.</p><p>Take the potential influence of several cognitive biases in DAs into account, and its influence on treatment decision making.</p><p>Interaction methods that elicit patients' values and preferences of treatment options were rarely used.</p><p>Provide (active) interactive exercises that help patients clarify their values and preferences.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Suitability of information</head><p>Some were quite lengthy and most were fixed in terms of size and format.</p><p>Develop multiple formats of the DA (paper-based versus web-based), or providing variation in terms of size (short versus elaborated DAs).</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Accessibility of information</head><p>Few were up-to-date and/or freely available to patients, some required login information to get full access.</p><p>Consider how DAs can be dynamically updated based on new evidence and patient data in order to facilitate maintenance and implementation of the tools.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Source of information</head><p>Original sources of probability information were most of the time unknown.</p><p>Provide reliable sources of information to help patients better understand how to apply the probabilities to their own situation.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="5.">Conclusions</head><p>The integration of DAs for LPC into daily clinical practice is becoming an important intervention to support patient participation in SDM <ref type="bibr" target="#b4">4,</ref><ref type="bibr" target="#b5">5,</ref><ref type="bibr" target="#b55">55</ref> . </p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="6.">Acknowledgments</head><p>We would like to thank Kim Tenfelde for her help with assessing part of the decision aids, and Robin Vernooij for developing the search strategy.    Outcome probabilities The DST provides information about outcome probabilities associated with the options (i.e, the likely consequences of decisions)</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="17">10</head><p>The DST specifies the defined group (reference class) of patients for which the outcome probabilities apply</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="10">11</head><p>The DST specifies the event rates for the outcome probabilities</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="14">12</head><p>The DST specifies the time period over which the outcome probabilities apply</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="8">13</head><p>The DST allows the user to compare outcome probabilities across options using the same denominator and time period</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="10">14</head><p>The DST provides information about the levels of uncertainty around event or outcome probabilities</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="11">15</head><p>The DST provides more than one way of viewing the probabilities</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="9">16</head><p>The DST provides balanced information about event or outcome probabilities to limit framing bias The DST (or associated paper) mentions that the development process included expert review by clients/patients not involved in producing the DST</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="9">26</head><p>The DST (or associated paper) mentions that the development process included expert review by health professionals not involved in producing the DST <ref type="bibr">16 27</ref> The DST (or associated paper) mentions that the DST was field tested with patients who were facing the decision 8</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>28</head><p>The DST (or associated paper) mentions that the DST was field tested with practitioners who counsel patients who face the decision 7</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>29</head><p>Using evidence The DST (or associated paper) provides citations to the studies selected</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="12">30</head><p>The DST (or associated paper) describes how research evidence was selected or synthesized <ref type="bibr">13 31</ref> The DST (or associated paper) provides a production or publication rate</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="12">32</head><p>The DST (or associated paper) provides information about the proposed update policy  The decision aid shows the progress of the decision aid 8</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>45</head><p>The decision aid provides patients a summary of their values and lllpreferences</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="7">46</head><p>The decision aid permits printing as a single document 11</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>47</head><p>The decision aid provides space for note taking 8</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>48</head><p>The decision aid includes a short knowledge test 3</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="49">Information control</head><p>The decision aid allows for patients to only receive information that they want to read</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="11">50</head><p>The decision aid provides a step-by-step way to move through the decision aid</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="18">51</head><p>The decision aid provides the patient the opportunity to read more about a specific topic of interest</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="16">52</head><p>The decision aid provides access to external sources 17</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>53</head><p>The decision aid provides access to internal sources 11</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>54</head><p>The decision aid allows for patients to search for key words 16</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="55">a</head><p>The decision aid makes it easy for patients to return to previous parts of the decision aid (n=12)</p></div><figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_0"><head>2. 4 .</head><label>4</label><figDesc>1 IPDAS. The IPDAS instrument 23 consisted of 36 items divided into eight dimensions (Appendix B): information about options, outcome probabilities, clarifying values, decision guidance, development process, using evidence, disclosure and transparency, and plain language. Since not all DAs had associated studies, we decided to exclude the items related to the evaluation dimension. Response options for each criteria item were 'yes'</figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_1"><head>Figure 1</head><label>1</label><figDesc>illustrates the flow chart of this systematic review. A search through databases resulted in 8501 records, and an additional 2 records through other sources. After removing 2025 duplicates, 6478 unique records were identified. Titles and abstracts were screened to identify 103 potentially eligible records. Initially, full text review of these records resulted in 25 articles that met eligibility criteria, including 17 unique DAs through published literature. However, given that full access to the DAs was required for inclusion in this review, we eventually included 16 articles including 10 unique and accessible DAs. An additional search through online sources resulted in another 18 DAs, leading to a total of 28 potential eligible DAs. After removing 9 duplicates, a total of 19 DAs was included in this review. General characteristics of the included DAs are shown in Table 1. Ten aids originated from the United States, eight from Europe, and one from Canada. Thirteen aids were written in English, and six in Dutch. Twelve of the DAs were web-based, and seven were paper-based. Year of publication/last update ranged from 2007 to 2018, and almost all DAs contained the most common contemporary treatment options for LPC (active surveillance, radical prostatectomy, external beam radiotherapy, and brachytherapy).</figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_2"><head>Figure 1 .</head><label>1</label><figDesc>Flowchart of Study and Decision Aid Selection Process.</figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_3"><head></head><label></label><figDesc>Note: AS = Active Surveillance; BT = Brachytherapy; CT = Cryotherapy; EBRT = External Beam Therapy; HIFU = High Intensity Focused Ultrasound; HT = Hormonal Therapy; IMRT = Intensity-Modulated Radiation Therapy; PBT = Proton Beam Therapy; RP = Radical Prostatectomy; RoP = Robot Prostatectomy; RT = Radiation Therapy; TURP = Transurethral Resection of Prostate; WW = Watchful Waiting; Minor discussed treatments are shown in parentheses.</figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_4"><head></head><label></label><figDesc>B. The percentage of IPDAS criteria met by the DAs ranged from 36% to 84% (M = 59%, SD = 12%). Ten of the 19 DAs included comparisons between positive and negative features of treatment options (53%), and 5 (26%) showed both features with equal detail. Regarding probabilities, ten DAs (53%) did not define the reference class, 11 (58%) did not mention the specified time period, and 15 (79%) did not provide balanced information about outcome probabilities. Only 2 DAs (11%) mentioned the readability levels of their aid, and most had low scores on items related to the development process (5 out of 6</figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_5"><head>Figure 2 .</head><label>2</label><figDesc>Percentage of items met on the IPDAS and CA checklist for each decision aid.</figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_6"><head>Figure 3 .</head><label>3</label><figDesc>Violin plots of the percentages of items met on the IPDAS checklist separated for each dimension (A), and percentage of items met on the CA checklist separated for each aspect (B). For each violin plot, dark dots represent the DAs.</figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_7"><head>4 ( 6 (</head><label>46</label><figDesc>26%), followed by pie and bar charts (2 and 1 respectively; 11% and 5%). The majority of the included DAs described uncertainties around probability information (15; 79%), of which all used verbal descriptions, 11 numerical ranges (73%), whilst only 1 communicated this visually (7%). Of the 16 DAs that explained disease-related factors, 25%) used text-only, whilst the majority used both text and illustrations (75%). All DAs communicated the procedures of treatments verbally, of which 7 (37%) added illustrations and 3 (16%) included video clips. Furthermore, only 2 DAs (11%) presented the information in a balanced and unbiased way, 10 (53%) used roughly the same amount of text for each option, and 7 (37%) used language that was biased in favor of a specific treatment. Finally, of the 16 aids that contained positive features of treatment options, 38%) provided an equal number of those features across options; whereas all aids contained negative features of options, of which 4 (21%) had an equal number of those features across options.</figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_8"><head></head><label></label><figDesc>the 16 DAs that helped patients to consider personal values and preferences, all passively asked patients to think about their personal values, and 10 (63%) used interactive methods such as weighting exercises (7; 44%) and/or sliders to assign values to preferences (4; 25%). Treatment comparison was realized by 13 aids (68%). Of these, cross-tables including positive and negative features of treatments were a principle feature (11; 84%), along with verbal comparisons (9; 69%). Only 5 (39%) incorporated interactive methods such as rating or ranking exercises, and 1 (8%) provided the patient with the most suitable option on the basis of values and preferences. Finally, feedback was given in various ways. Eight DAs (42%) showed the progress of the aid, 7 (37%) provided a summary of the values and preferences, and 11 (58%) had the opportunity to print the DA as a single document. In addition, 8 DAs (42%) provided space for note taking, and 3 (16%) included a short knowledge test.</figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_9"><head>Furthermore, only a</head><label></label><figDesc>small number of DAs contained interactive methods to assess patients' values and preferences, or to compare pros and cons of the available options. This aspects of interaction is particularly important for preference-sensitive decisions such as for LPC, in which there is typically no single best option. The majority of the aids incorporated interaction methods such as a side-by-side table of the positive and negative features of options. Interestingly, our analyses also demonstrated that many of these tables included biases such as an unequal number of positive and negative features of treatments, or a dissimilar amount of text for each option. Such (cognitive) biases could unintentionally influence patients' decision making 53 . It is important that such potential biases are taken into consideration during the development and use of DAs.</figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_10"><head></head><label></label><figDesc>are involved in the development of DAs might consider how such tools can be dynamically updated based on new evidence and patient data in order to facilitate maintenance and implementation of the tools. Here, again, recent technological advances may be helpful. Finally, an interesting question is whether DAs with high scores on CAs also lead to improved quality of decision making or other outcome measures of SDM. This could not be investigated in the current review, since we could not link the outcome measures of the reported trials with our assessment measures. Rather, our main focus was on conducting a systematic description of the use of CAs and IPDAS criteria by currently available DAs for LPC treatment, in order to determine its shortcomings. Nevertheless, this is an important issue, and future studies are needed in order to determine whether improved communicative characteristics of DAs in (prostate) cancer care will lead to improvements in SDM outcomes such as decisional conflict, decisional regret, knowledge, or preparation for decision making.</figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_11"><head></head><label></label><figDesc>Using insights from communication research and relying on technological advances in artificial intelligence research, we argue that patient DAs for LPC treatment could be further improved by taking CAs such as personalization of treatment information, interaction, and the possible channels to communicate information into account. Such improvements are not only limited to the domain of prostate cancer care, but are also useful to many other decisions in health care that do not have a single best option. We therefore believe that our findings have implications for both clinicians who are making use of DAs in daily clinical practice, as well as for clinicians who are involved in the development of such decision support tools.</figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_12"><head></head><label></label><figDesc>or associated technical documentation) provides information about the funding used for development13   35   The DST includes author / developer credentials or qualifications18 36 Plain language The DST (or associated paper) reports readability levels (using one or more of the available scales) Methods used to consider or assess values and preferences (n=16): Passive methods 35 Recommends patients to think about their values and preferences Asks patients for their personal values and preferences aids that help allow for comparison of positive and negative features of treatment options 13 Methods used to compare positive and negative features of options (n=13): 39 Ranking or rating scale 5 40</figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_0"><head>Table 1 .</head><label>1</label><figDesc>Summary of the Decision Aids Included in the Systematic Review.</figDesc><table><row><cell>ID Title</cell><cell>Organization/Authors</cell><cell cols="2">Country Target</cell><cell>Publication date</cell><cell>Treatments</cell><cell cols="2">Format Identified</cell></row><row><cell></cell><cell></cell><cell></cell><cell>audience</cell><cell>(last update)</cell><cell>discussed</cell><cell></cell><cell>through</cell></row><row><cell>Proven best choices:</cell><cell>Institute for Clinical and</cell><cell>USA</cell><cell>Low risk</cell><cell>Unknown</cell><cell>AS, RP, BT</cell><cell>Paper</cell><cell>Online</cell></row><row><cell>Treatment options for men with</cell><cell>Economic Review (ICER)</cell><cell></cell><cell></cell><cell>(Unknown)</cell><cell>(IMRT, PBT)</cell><cell></cell><cell>sources</cell></row><row><cell>low-risk prostate cancer</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>De keuze maken:</cell><cell>KU Leuven LUCAS,</cell><cell>BE</cell><cell>Localized,</cell><cell>Oct 2007</cell><cell>WW, RP, EBRT,</cell><cell>Paper</cell><cell>Published</cell></row><row><cell>Beslissingshulp voor patiënten</cell><cell>Isebaert 31,32</cell><cell></cell><cell>early-stage</cell><cell>(Unknown)</cell><cell>BT</cell><cell></cell><cell>literature</cell></row><row><cell>met vroegtijdige stadium</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>gelokaliseerde prostaatkanker</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>Healing choices for men with</cell><cell>Mount Sinai Medical Center,</cell><cell>USA</cell><cell>Localized,</cell><cell>2008</cell><cell>AS, RP, EBRT,</cell><cell>Web</cell><cell>Published</cell></row><row><cell>prostate cancer</cell><cell>Fox Chase Cancer Center,</cell><cell></cell><cell>early-stage</cell><cell>(Unknown)</cell><cell>BT</cell><cell></cell><cell>literature</cell></row><row><cell></cell><cell>Diefenbach 45</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>Beslissingshulp voor patiënten</cell><cell>KU Leuven LUCAS,</cell><cell>BE</cell><cell>Localized,</cell><cell>2010</cell><cell>WW, RP, EBRT,</cell><cell>Web</cell><cell>Published</cell></row><row><cell>met vroegtijdige, gelokaliseerde</cell><cell>Schrijvers 46</cell><cell></cell><cell>early-stage</cell><cell>(Unknown)</cell><cell>BT</cell><cell></cell><cell>literature</cell></row><row><cell>prostaatkanker</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>Treatment choices for men with</cell><cell>National Cancer Institute</cell><cell>USA</cell><cell>Early-stage</cell><cell>Jan 2011</cell><cell>AS, RP, EBRT,</cell><cell>Paper</cell><cell>Online</cell></row><row><cell>early-stage prostate cancer</cell><cell></cell><cell></cell><cell></cell><cell>(Unknown)</cell><cell>BT, HT (IMRT,</cell><cell></cell><cell>sources</cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>PBT, CT)</cell><cell></cell><cell></cell></row><row><cell>Knowing your options: A</cell><cell>Agency for Healthcare</cell><cell>USA</cell><cell>Localized</cell><cell>Sep 2011</cell><cell>AS, RP, EBRT,</cell><cell>Web</cell><cell>Online</cell></row><row><cell>decision aid for men with</cell><cell>Research and Quality</cell><cell></cell><cell></cell><cell>(Unknown)</cell><cell>BT, HT (HIFU,</cell><cell></cell><cell>sources</cell></row><row><cell>clinically localized prostate</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>PBT, CT)</cell><cell></cell><cell></cell></row><row><cell>cancer</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>Keuzehulp prostaatkanker</cell><cell>VU Medical Center,</cell><cell>NL</cell><cell>Localized</cell><cell>Sep 2013</cell><cell>AS, RP, EBRT,</cell><cell>Web</cell><cell>Published</cell></row><row><cell></cell><cell>De Argumentenfabriek,</cell><cell></cell><cell></cell><cell>(Unknown)</cell><cell>BT</cell><cell></cell><cell>literature</cell></row><row><cell></cell><cell>Al-Itejawi 33,34</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>Keuzehulp voor mannen met</cell><cell>Radboud UMC Nijmegen,</cell><cell>NL</cell><cell>Localized</cell><cell>2012</cell><cell>AS, RP, EBRT,</cell><cell>Paper</cell><cell>Published</cell></row><row><cell>gelokaliseerde prostaatkanker</cell><cell>KWF Kankerbestrijding,</cell><cell></cell><cell></cell><cell>(2014)</cell><cell>BT (HIFU, CT)</cell><cell></cell><cell>literature</cell></row><row><cell></cell><cell>Prostaatkankerstichting,</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell></cell><cell>van Tol-Geerdink 35,36</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>Making the choice: Deciding</cell><cell>Michigan Cancer</cell><cell>USA</cell><cell>Early-stage</cell><cell>2004</cell><cell>AS, WW, RP,</cell><cell>Paper</cell><cell>Published</cell></row><row><cell>what to do about early-stage</cell><cell>Consortium,</cell><cell></cell><cell></cell><cell>(Apr 2014)</cell><cell>EBRT, BT (CT)</cell><cell></cell><cell>literature</cell></row><row><cell>prostate cancer</cell><cell>Holmes-Rovner 37</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row></table><note></note></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_1"><head>Table 2 .</head><label>2</label><figDesc>Summary of the Studies Included in the Systematic Review.</figDesc><table><row><cell>DA ID</cell><cell cols="3">First author, year Country Study design</cell><cell>Study population</cell><cell>Methods</cell><cell>Results</cell></row><row><cell>2</cell><cell>Isebaert, 31</cell><cell>BE</cell><cell>Evaluation study</cell><cell>Newly diagnosed</cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell>LPC patients (n=50)</cell></row></table><note></note></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_4"><head>Table 3 .</head><label>3</label><figDesc>Overview of Communicative Issues and Recommendations for Clinicians in the Development and Use of Decision Aids for Localized Prostate Cancer Treatment.</figDesc><table><row><cell>Communicative</cell><cell>Issues observed in DAs</cell><cell>Recommendations for clinicians</cell></row><row><cell>aspect</cell><cell></cell><cell></cell></row></table><note></note></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_6"><head>Table A</head><label>A</label><figDesc></figDesc><table><row><cell>S22</cell><cell>TX shared decision making</cell></row><row><cell>S23</cell><cell>S18 OR S19 OR S20 OR S21 OR S22</cell></row><row><cell>S24</cell><cell>S17 OR S24</cell></row><row><cell>S25</cell><cell>(MH "Patients")</cell></row><row><cell>S26</cell><cell>(MH "Consumer Participation")</cell></row><row><cell>S27</cell><cell>(MH "Patient Education")</cell></row><row><cell>S28</cell><cell>(MH "Patient Satisfaction")</cell></row><row><cell>S29</cell><cell>S25 OR S26 OR S27 OR S28</cell></row><row><cell>S30</cell><cell>.3. Search strategy CINAHL. S24 OR S29</cell></row><row><cell>S31</cell><cell>(MH "Prostatectomy")</cell></row><row><cell>S1 S32</cell><cell>(MH "Prostatic Neoplasms") AB (prostatectom* OR (transurethral* AND (resection* OR removal*) AND prostat*)) OR TI</cell></row><row><cell>S2</cell><cell>AB (prostat* AND neoplas*) AND TI (prostat* AND neoplas*) (prostatectom* OR (transurethral* AND (resection* OR removal*) AND prostat*))</cell></row><row><cell>S3 S33</cell><cell>AB (prostat* AND cancer*) AND TI (prostat* AND cancer*) S31 OR S32</cell></row><row><cell>S4 S34</cell><cell>AB (prostat* AND carcin*) AND TI (prostat* AND carcin*) (MH "Radiotherapy")</cell></row><row><cell>S5 S35</cell><cell>AB (prostat* AND tumour*) AND TI (prostat* AND tumour*) AB (radiotherap*) OR TI (radiotherapy*)</cell></row><row><cell>S6 S36</cell><cell>AB (prostat* AND tumor*) AND TI (prostat* AND tumor*) S34 OR S35</cell></row><row><cell>S7 S37</cell><cell>AB (prostat* AND metasta*) AND TI (prostat* AND metasta*) AB ((Watchful* AND waiting*) OR (active AND surveillance))</cell></row><row><cell>S8 S38</cell><cell>AB (prostat* AND malig*) AND TI (prostat* AND malig*) TI ((Watchful* AND waiting*) OR (active AND surveillance))</cell></row><row><cell>S9 S39</cell><cell>(MH "Prostate") S37 OR S38</cell></row><row><cell>S10 S40</cell><cell>AB (neoplas* OR cancer* OR carcin* OR tumo* OR metasta* OR malig*) OR TI (neoplas* (MH "Hormone Replacement Therapy")</cell></row><row><cell>S41</cell><cell>OR cancer* OR carcin* OR tumo* OR metasta* OR malig*) OR (MS "Neoplasms") (MH "Hormone Therapy")</cell></row><row><cell>S11 S42</cell><cell>S9 AND S10 AB (Hormon* AND therap*) OR TI (Hormon* AND therap*) OR TI (</cell></row><row><cell>S12 S43</cell><cell>S1 OR S2 OR S3 OR S4 OR S5 OR S6 OR S7 OR S8 OR S11 S40 OR S41 OR S42</cell></row><row><cell>S13 S44</cell><cell>(MH "Decision Making") AB (treatment*) OR TI (treatment*)</cell></row><row><cell>S14 S45</cell><cell>(MH "Decision Making, Clinical") (MH "Prostatic Neoplasms/TH")</cell></row><row><cell>S15 S46</cell><cell>(MH "Decision Support Systems, Clinical") S33 OR S36 OR S39 OR S43 OR S44 OR S45</cell></row><row><cell>S16 S47</cell><cell>(MH "Decision Support Techniques") S12 AND S30 AND S46</cell></row><row><cell>S17 S48</cell><cell>S13 OR S14 OR S15 OR S16 S47: Limiters -(English language)</cell></row><row><cell>S18</cell><cell>AB (decision* OR decid*) AND (support* OR tool* OR aid* OR instrument* OR technolog*</cell></row><row><cell></cell><cell>OR system*) OR TI (decision* OR decid*) AND (support* OR tool* OR aid* OR instrument*</cell></row><row><cell></cell><cell>OR technolog* OR system*)</cell></row><row><cell>S19</cell><cell>TX decision aid*</cell></row><row><cell>S20</cell><cell>TX interactive health communication</cell></row><row><cell>S21</cell><cell>TX (interacti* AND (internet OR online OR graphic* OR booklet* OR leaflet* OR tool))</cell></row></table><note></note></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_7"><head>Table A . 4 .</head><label>A4</label><figDesc>Search strategy Cochrane Library. AND cancer*):ti, ab, kw (Word variations have been searched) (prostat* AND carcin*):ti, ab, kw (Word variations have been searched) (prostat* AND tumour*):ti, ab, kw (Word variations have been searched)</figDesc><table><row><cell></cell><cell>(prostat* (prostat* AND tumor*):ti, ab, kw (Word variations have been searched)</cell></row><row><cell></cell><cell>(prostat* AND metasta*):ti, ab, kw (Word variations have been searched)</cell></row><row><cell></cell><cell>(prostat* AND malig*):ti, ab, kw (Word variations have been searched)</cell></row><row><cell>1</cell><cell>MeSH descriptor: [Prostatic Neoplasms] explode all trees</cell></row><row><cell>2</cell><cell>(prostat* AND neoplas*):ti, ab, kw (Word variations have been searched)</cell></row></table><note></note></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_8"><head>Table B . 1 .</head><label>B1</label><figDesc>Results from the International Patient Decision Aids Standards (IPDAS) Checklist of the Patient Decision Aids (n=19).</figDesc><table><row><cell cols="2">Item IPDAS dimension</cell><cell>Item description</cell><cell>n</cell><cell>%</cell></row><row><cell>1</cell><cell>Information about</cell><cell>The DST describes the health condition or problem</cell><cell>19</cell></row><row><cell></cell><cell>options</cell><cell>(intervention, procedure, or investigation) for which the index</cell><cell></cell></row><row><cell></cell><cell></cell><cell>decision is required</cell><cell></cell></row><row><cell>2</cell><cell></cell><cell>The DST described the decision that needs to be considered</cell><cell>18</cell></row><row><cell></cell><cell></cell><cell>(the index decision)</cell><cell></cell></row><row><cell>3</cell><cell></cell><cell>The DST describes the options available for the index</cell><cell>19</cell></row><row><cell></cell><cell></cell><cell>decision</cell><cell></cell></row><row><cell>4</cell><cell></cell><cell>The DST describes the natural course of the health condition</cell><cell>17</cell></row><row><cell></cell><cell></cell><cell>or problem, if no action is taken</cell><cell></cell></row><row><cell>5</cell><cell></cell><cell>The DST describes positive features (benefits or</cell><cell>15</cell></row><row><cell></cell><cell></cell><cell>advantages) of each option</cell><cell></cell></row><row><cell>6</cell><cell></cell><cell>The DST describes negative features (harms, side effects or</cell><cell>19</cell></row><row><cell></cell><cell></cell><cell>disadvantages) of each option</cell><cell></cell></row><row><cell>7</cell><cell></cell><cell>The DST makes it possible to compare the positive and</cell><cell>10</cell></row><row><cell></cell><cell></cell><cell>negative features of the available options</cell><cell></cell></row><row><cell>8</cell><cell></cell><cell>The DST shows the negative and positive features of options</cell><cell>5</cell></row><row><cell></cell><cell></cell><cell>with equal detail</cell><cell></cell></row><row><cell>9</cell><cell></cell><cell></cell><cell></cell></row></table><note></note></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_9"><head></head><label></label><figDesc>The DST describes the features of options to help patients imagine what it is like to experience physical effects The DST describes the features of options to help patients imagine what it is like to experience the psychological effects 7 19The DST describes the features of options to help patients imagine what it is like to experience social effects 10 20The DST asks patients to think about which positive and negative features of the options matters most to them</figDesc><table><row><cell></cell><cell></cell><cell></cell><cell>14</cell></row><row><cell>21</cell><cell>Decision guidance</cell><cell>The DST provides a step-by-step way to make a decision</cell><cell>13</cell></row><row><cell>22</cell><cell></cell><cell>The DST includes tools like worksheets or lists of questions</cell><cell>12</cell></row><row><cell></cell><cell></cell><cell>to use when discussing options with a practitioner</cell><cell></cell></row><row><cell>23</cell><cell>Development process</cell><cell>The DST (or associated paper) mentions that the</cell><cell>6</cell></row><row><cell></cell><cell></cell><cell>development process included finding out what clients or</cell><cell></cell></row><row><cell></cell><cell></cell><cell>patients need to prepare them to discuss a decision</cell><cell></cell></row><row><cell>24</cell><cell></cell><cell>The DST (or associated paper) mentions that the</cell><cell>4</cell></row><row><cell></cell><cell></cell><cell>development process included finding out what health</cell><cell></cell></row><row><cell></cell><cell></cell><cell>professionals need to prepare them to discuss a specific</cell><cell></cell></row><row><cell></cell><cell></cell><cell>decision with patients</cell><cell></cell></row><row><cell>25</cell><cell></cell><cell></cell><cell></cell></row><row><cell></cell><cell></cell><cell></cell><cell>4</cell></row><row><cell>17</cell><cell>Clarifying values</cell><cell></cell><cell></cell></row></table><note></note></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_10"><head>Table to</head><label>to</label><figDesc></figDesc><table><row><cell></cell><cell>compare positive and negative features</cell><cell>11</cell></row><row><cell>41</cell><cell>Verbal comparisons</cell><cell>9</cell></row><row><cell>42</cell><cell>Discrete choice task</cell><cell>1</cell></row><row><cell>43</cell><cell>Number of decision aids that provide patient the most suitable</cell><cell>1</cell></row><row><cell></cell><cell>treatment option</cell><cell></cell></row><row><cell></cell><cell>Methods used to provide feedback:</cell><cell></cell></row><row><cell>44</cell><cell></cell><cell></cell></row></table><note></note></figure>
		</body>
		<back>
			<div type="annex">
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Appendix A</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Appendix B</head><p>Note. DST = Decision support technology.</p><p>Appendix C About the number of patients on which the data are based on 1</p><p>About characteristics of patients on which the data are based on 0</p><p>About the period of time of data collection 1 17</p><p>Note. a This item does not apply to paper-based decision aids.</p></div>			</div>
			<div type="references">

				<listBibl>

<biblStruct xml:id="b0">
	<monogr>
		<title level="m" type="main">The diagnosis and treatment of prostate cancer: A review</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><forename type="middle">S</forename><surname>Litwin</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">H-J</forename><surname>Tan</surname></persName>
		</author>
		<imprint/>
	</monogr>
</biblStruct>

<biblStruct xml:id="b1">
	<analytic>
		<title/>
		<idno type="DOI">10.1001/jama.2017.7248</idno>
	</analytic>
	<monogr>
		<title level="j">Jama</title>
		<imprint>
			<biblScope unit="volume">317</biblScope>
			<biblScope unit="issue">24</biblScope>
			<biblScope unit="page" from="2532" to="2542" />
			<date type="published" when="2017" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b2">
	<analytic>
		<title level="a" type="main">10-Year outcomes after monitoring, surgery, or radiotherapy for localized prostate cancer</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">F</forename><forename type="middle">C</forename><surname>Hamdy</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><forename type="middle">L</forename><surname>Donovan</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><forename type="middle">A</forename><surname>Lane</surname></persName>
		</author>
		<idno type="DOI">10.1056/NEJMoa1606220</idno>
	</analytic>
	<monogr>
		<title level="j">N Engl J Med</title>
		<imprint>
			<biblScope unit="volume">375</biblScope>
			<biblScope unit="issue">15</biblScope>
			<biblScope unit="page" from="1415" to="1424" />
			<date type="published" when="2016" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b3">
	<analytic>
		<title level="a" type="main">Patient-reported outcomes after monitoring, surgery, or radiotherapy for prostate cancer</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><forename type="middle">L</forename><surname>Donovan</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">F</forename><forename type="middle">C</forename><surname>Hamdy</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><forename type="middle">A</forename><surname>Lane</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.juro.2017.02.004</idno>
	</analytic>
	<monogr>
		<title level="j">J Urol</title>
		<imprint>
			<biblScope unit="volume">375</biblScope>
			<biblScope unit="issue">15</biblScope>
			<biblScope unit="page" from="1425" to="1437" />
			<date type="published" when="2017" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b4">
	<analytic>
		<title level="a" type="main">Shared decision making: A model for clinical practice</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">G</forename><surname>Elwyn</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">D</forename><surname>Frosch</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">R</forename><surname>Thomson</surname></persName>
		</author>
		<idno type="DOI">10.1007/s11606-012-2077-6</idno>
	</analytic>
	<monogr>
		<title level="j">J Gen Intern Med</title>
		<imprint>
			<biblScope unit="volume">27</biblScope>
			<biblScope unit="issue">10</biblScope>
			<biblScope unit="page" from="1361" to="1367" />
			<date type="published" when="2012" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b5">
	<analytic>
		<title level="a" type="main">A three-talk model for shared decision making: Multistage consultation process</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">G</forename><surname>Elwyn</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><forename type="middle">A</forename><surname>Durand</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><surname>Song</surname></persName>
		</author>
		<idno type="DOI">10.1136/bmj.j4891</idno>
	</analytic>
	<monogr>
		<title level="j">BMJ</title>
		<imprint>
			<biblScope unit="volume">359</biblScope>
			<biblScope unit="page" from="1" to="7" />
			<date type="published" when="2017" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b6">
	<analytic>
		<title level="a" type="main">Ten years of the International Patient Decision Aid Standards Collaboration: evolution of the core dimensions for assessing the quality of patient decision aids</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">R</forename><forename type="middle">J</forename><surname>Volk</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">H</forename><surname>Llewellyn-Thomas</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">D</forename><surname>Stacey</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">G</forename><surname>Elwyn</surname></persName>
		</author>
		<idno type="DOI">10.1186/1472-6947-13-S2-S1</idno>
	</analytic>
	<monogr>
		<title level="j">BMC Med Inform Decis Mak</title>
		<imprint>
			<biblScope unit="volume">13</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page">1</biblScope>
			<date type="published" when="2013" />
		</imprint>
	</monogr>
	<note>Suppl</note>
</biblStruct>

<biblStruct xml:id="b7">
	<analytic>
		<title level="a" type="main">Decision aids for people facing health treatment or screening decisions</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">D</forename><surname>Stacey</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">F</forename><surname>Légaré</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">K</forename><surname>Lewis</surname></persName>
		</author>
		<idno type="DOI">10.1002/14651858.CD001431.pub5</idno>
	</analytic>
	<monogr>
		<title level="j">Cochrane Database Syst Rev</title>
		<imprint>
			<biblScope unit="issue">4</biblScope>
			<date type="published" when="2017" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b8">
	<analytic>
		<title level="a" type="main">Patient decision aids for prostate cancer treatment: A systematic review of the literature</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">G</forename><forename type="middle">A</forename><surname>Lin</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">D</forename><forename type="middle">S</forename><surname>Aaronson</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">S</forename><forename type="middle">J</forename><surname>Knight</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">P</forename><forename type="middle">R</forename><surname>Carroll</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">R</forename><forename type="middle">A</forename><surname>Dudley</surname></persName>
		</author>
		<idno type="DOI">10.3322/caac.20039</idno>
	</analytic>
	<monogr>
		<title level="j">CA Cancer J Clin</title>
		<imprint>
			<biblScope unit="volume">59</biblScope>
			<biblScope unit="issue">6</biblScope>
			<biblScope unit="page" from="379" to="390" />
			<date type="published" when="2009" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b9">
	<analytic>
		<title level="a" type="main">Decision aids for localized prostate cancer treatment choice: Systematic review and meta-analysis</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">P</forename><forename type="middle">D</forename><surname>Violette</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">T</forename><surname>Agoritsas</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">P</forename><surname>Alexander</surname></persName>
		</author>
		<idno type="DOI">10.3322/caac.21272</idno>
	</analytic>
	<monogr>
		<title level="j">CA Cancer J Clin</title>
		<imprint>
			<biblScope unit="volume">65</biblScope>
			<biblScope unit="issue">3</biblScope>
			<biblScope unit="page" from="239" to="251" />
			<date type="published" when="2015" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b10">
	<analytic>
		<title level="a" type="main">Systematic Review of Decision Aids for the Management of Men With Localized Prostate Cancer</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">W</forename><surname>Zhong</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">B</forename><surname>Smith</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">K</forename><surname>Haghighi</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">P</forename><surname>Mancuso</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.urology.2017.10.022</idno>
	</analytic>
	<monogr>
		<title level="j">Urology</title>
		<imprint>
			<biblScope unit="volume">114</biblScope>
			<biblScope unit="page" from="1" to="7" />
			<date type="published" when="2018" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b11">
	<monogr>
		<title level="m" type="main">Aiding medical decision making: A communication perspective</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">R</forename><forename type="middle">L</forename><surname>Street</surname></persName>
		</author>
		<idno type="DOI">10.1177/0272989X07307581</idno>
		<imprint>
			<date type="published" when="2007" />
			<biblScope unit="volume">27</biblScope>
			<biblScope unit="page" from="550" to="553" />
		</imprint>
	</monogr>
	<note>Med Decis Mak</note>
</biblStruct>

<biblStruct xml:id="b12">
	<analytic>
		<title level="a" type="main">The mathematical theory of communication</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">C</forename><surname>Shannon</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">W</forename><surname>Weaver</surname></persName>
		</author>
		<idno type="DOI">10.1145/584091.584093</idno>
	</analytic>
	<monogr>
		<title level="j">Univ Illinois Press</title>
		<imprint>
			<biblScope unit="volume">5</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="1" to="131" />
			<date type="published" when="1949" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b13">
	<analytic>
		<title level="a" type="main">A communication model of shared decision making: Accounting for cancer treatment decisions</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">L</forename><forename type="middle">A</forename><surname>Siminoff</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><forename type="middle">M</forename><surname>Step</surname></persName>
		</author>
		<idno type="DOI">10.1037/0278-6133.24.4.S99</idno>
	</analytic>
	<monogr>
		<title level="j">Heal Psychol</title>
		<imprint>
			<biblScope unit="volume">24</biblScope>
			<biblScope unit="issue">4</biblScope>
			<date type="published" when="2005" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b14">
	<analytic>
		<title level="a" type="main">A conceptual framework for patient -professional communication: An application to the cancer context</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">D</forename><surname>Feldman-Stewart</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><forename type="middle">D</forename><surname>Brundage</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">C</forename><surname>Tishelman</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">S</forename><forename type="middle">C</forename><surname>Team</surname></persName>
		</author>
		<idno type="DOI">10.1002/pon.950</idno>
	</analytic>
	<monogr>
		<title level="j">Psychooncology</title>
		<imprint>
			<biblScope unit="volume">14</biblScope>
			<biblScope unit="issue">10</biblScope>
			<biblScope unit="page" from="801" to="809" />
			<date type="published" when="2005" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b15">
	<monogr>
		<title level="m" type="main">The Cambridge Handbook of Multimedia Learning</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">R</forename><forename type="middle">E</forename><surname>Mayer</surname></persName>
		</author>
		<idno type="DOI">10.1207/s15326985ep4102_2</idno>
		<editor>Mayer RE</editor>
		<imprint>
			<date type="published" when="2005" />
			<publisher>Cambridge University Press</publisher>
			<biblScope unit="page" from="31" to="48" />
			<pubPlace>Cambridge</pubPlace>
		</imprint>
	</monogr>
	<note>Cognitive theory of multimedia learning</note>
</biblStruct>

<biblStruct xml:id="b16">
	<analytic>
		<title level="a" type="main">Integrated model of text and picture comprehension</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">W</forename><surname>Schnotz</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="m">The Cambridge Handbook of Multimedia Learning</title>
		<editor>Mayer RE</editor>
		<meeting><address><addrLine>Cambridge</addrLine></address></meeting>
		<imprint>
			<publisher>Cambridge University Press</publisher>
			<date type="published" when="2005" />
			<biblScope unit="page" from="49" to="70" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b17">
	<analytic>
		<title level="a" type="main">Implication of cognitive load theory for multimedia learning</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><surname>Sweller</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="m">The Cambridge Handbook of Multimedia Learning</title>
		<editor>Mayer RE</editor>
		<meeting><address><addrLine>Cambridge</addrLine></address></meeting>
		<imprint>
			<publisher>Cambridge University Press</publisher>
			<date type="published" when="2005" />
			<biblScope unit="page" from="19" to="30" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b18">
	<analytic>
		<title level="a" type="main">Helping doctors and patients make sense of health statistics</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">G</forename><surname>Gigerenzer</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">W</forename><surname>Gaissmaier</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">E</forename><surname>Kurz-Milcke</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">L</forename><forename type="middle">M</forename><surname>Schwartz</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">S</forename><surname>Woloshin</surname></persName>
		</author>
		<idno type="DOI">10.1111/j.1539-6053.2008.00033.x</idno>
	</analytic>
	<monogr>
		<title level="j">Psychol Sci Public Interes</title>
		<imprint>
			<biblScope unit="volume">8</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page" from="53" to="96" />
			<date type="published" when="2008" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b19">
	<analytic>
		<title level="a" type="main">Designing visual aids that promote risk literacy: A systematic review of health research and evidence-based design heuristics</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">R</forename><surname>Garcia-Retamero</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">E</forename><forename type="middle">T</forename><surname>Cokely</surname></persName>
		</author>
		<idno type="DOI">10.1177/0018720817690634</idno>
	</analytic>
	<monogr>
		<title level="j">Hum Factors J Hum Factors Ergon Soc</title>
		<imprint>
			<biblScope unit="volume">59</biblScope>
			<biblScope unit="issue">4</biblScope>
			<date type="published" when="2017" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b20">
	<analytic>
		<title level="a" type="main">Advancing tailored health communication: A persuasion and message effects perspective</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">B</forename><forename type="middle">K</forename><surname>Rimer</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><forename type="middle">W</forename><surname>Kreuter</surname></persName>
		</author>
		<idno type="DOI">10.1111/j.1460-2466.2006.00289.x</idno>
	</analytic>
	<monogr>
		<title level="j">J Commun</title>
		<imprint>
			<biblScope unit="volume">56</biblScope>
			<biblScope unit="page" from="184" to="201" />
			<date type="published" when="2006" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b21">
	<analytic>
		<title level="a" type="main">Taking online computer-tailoring forward: The potential of tailoring the message frame and delivery mode of online health behavior change interventions</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">E</forename><forename type="middle">S</forename><surname>Smit</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">A</forename><forename type="middle">J</forename><surname>Linn</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Jcm</forename><surname>Van Weert</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Eureopean Heal Pshychologist</title>
		<imprint>
			<biblScope unit="volume">17</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="25" to="31" />
			<date type="published" when="2013" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b22">
	<analytic>
		<title level="a" type="main">Challenges for designing and implementing decision aids</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">D</forename><surname>Feldman-Stewart</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><forename type="middle">D</forename><surname>Brundage</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.pec.2003.09.007</idno>
	</analytic>
	<monogr>
		<title level="j">Patient Educ Couns</title>
		<imprint>
			<biblScope unit="volume">54</biblScope>
			<biblScope unit="issue">3</biblScope>
			<biblScope unit="page" from="265" to="273" />
			<date type="published" when="2004" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b23">
	<analytic>
		<title level="a" type="main">Assessing the quality of decision support technologies using the International Patient Decision Aid Standards instrument (IPDASi)</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">G</forename><surname>Elwyn</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">A</forename><forename type="middle">M</forename><surname>O'connor</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">C</forename><surname>Bennett</surname></persName>
		</author>
		<idno type="DOI">10.1371/journal.pone.0004705</idno>
	</analytic>
	<monogr>
		<title level="j">PLoS One</title>
		<imprint>
			<biblScope unit="volume">4</biblScope>
			<biblScope unit="issue">3</biblScope>
			<date type="published" when="2009" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b24">
	<analytic>
		<title level="a" type="main">The loss of reason in patient decision aid research: Do checklists damage the quality of informed choice interventions?</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">H</forename><forename type="middle">L</forename><surname>Bekker</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.pec.2010.01.002</idno>
	</analytic>
	<monogr>
		<title level="j">Patient Educ Couns</title>
		<imprint>
			<biblScope unit="volume">78</biblScope>
			<biblScope unit="issue">3</biblScope>
			<biblScope unit="page" from="357" to="364" />
			<date type="published" when="2010" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b25">
	<analytic>
		<title level="a" type="main">Systematic review of decision aids for newly diagnosed patients with prostate cancer making treatment decisions</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">P</forename><surname>Adsul</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">R</forename><surname>Wray</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">K</forename><surname>Spradling</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">O</forename><surname>Darwish</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">N</forename><surname>Weaver</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">S</forename><surname>Siddiqui</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.juro.2015.05.093</idno>
	</analytic>
	<monogr>
		<title level="j">J Urol</title>
		<imprint>
			<biblScope unit="volume">194</biblScope>
			<biblScope unit="issue">5</biblScope>
			<biblScope unit="page" from="1247" to="1252" />
			<date type="published" when="2015" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b26">
	<analytic>
		<title level="a" type="main">The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: Explanation and elaboration</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">A</forename><surname>Liberati</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">D</forename><forename type="middle">G</forename><surname>Altman</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><surname>Tetzlaff</surname></persName>
		</author>
		<idno type="DOI">10.1136/bmj.b2700</idno>
	</analytic>
	<monogr>
		<title level="j">Bmj</title>
		<imprint>
			<biblScope unit="volume">339</biblScope>
			<biblScope unit="page" from="2700" to="2700" />
			<date type="published" when="2009" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b27">
	<analytic>
		<title level="a" type="main">Interrater reliability: The kappa statistic</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><forename type="middle">L</forename><surname>Mchugh</surname></persName>
		</author>
		<idno type="DOI">10.11613/BM.2012.031</idno>
	</analytic>
	<monogr>
		<title level="j">Biochem Medica</title>
		<imprint>
			<biblScope unit="volume">22</biblScope>
			<biblScope unit="issue">3</biblScope>
			<biblScope unit="page" from="276" to="282" />
			<date type="published" when="2012" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b28">
	<analytic>
		<title level="a" type="main">A review of decision support, risk communication and patient information tools for thrombolytic treatment in acute stroke: lessons for tool developers</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">D</forename><surname>Flynn</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">G</forename><forename type="middle">A</forename><surname>Ford</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">L</forename><surname>Stobbart</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">H</forename><surname>Rodgers</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><forename type="middle">J</forename><surname>Murtagh</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">R</forename><forename type="middle">G</forename><surname>Thomson</surname></persName>
		</author>
		<idno type="DOI">10.1186/1472-6963-13-225</idno>
	</analytic>
	<monogr>
		<title level="j">BMC Health Serv Res</title>
		<imprint>
			<biblScope unit="volume">13</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page">225</biblScope>
			<date type="published" when="2013" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b29">
	<analytic>
		<title level="a" type="main">Features of computerbased decision aids: Systematic review, thematic synthesis, and meta-analyses</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">A</forename><surname>Syrowatka</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">D</forename><surname>Krömker</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">A</forename><forename type="middle">N</forename><surname>Meguerditchian</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">R</forename><surname>Tamblyn</surname></persName>
		</author>
		<idno type="DOI">10.2196/jmir.4982</idno>
	</analytic>
	<monogr>
		<title level="j">J Med Internet Res</title>
		<imprint>
			<biblScope unit="volume">18</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="1" to="16" />
			<date type="published" when="2016" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b30">
	<monogr>
		<title level="m" type="main">Teaching Patients with Low Literacy Skills</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">C</forename><forename type="middle">C</forename><surname>Doak</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">L</forename><forename type="middle">G</forename><surname>Doak</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><forename type="middle">H</forename><surname>Root</surname></persName>
		</author>
		<imprint>
			<date type="published" when="1996" />
			<pubPlace>Philadelphia, Pennsylvania</pubPlace>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b31">
	<analytic>
		<title level="a" type="main">Een beslissingshulp voor patiënten met gelokaliseerde prostaatkanker: Eerste resultaten</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">S</forename><surname>Isebaert</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">C</forename><surname>Van Audenhove</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">K</forename><surname>Haustermans</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Tijdschr Geneeskd</title>
		<imprint>
			<biblScope unit="volume">63</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="15" to="21" />
			<date type="published" when="2007" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b32">
	<analytic>
		<title level="a" type="main">Evaluating a decision aid for patients with localized prostate cancer in clinical practice</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">S</forename><surname>Isebaert</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">C</forename><surname>Van Audenhove</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">K</forename><surname>Haustermans</surname></persName>
		</author>
		<idno type="DOI">10.1159/000167833</idno>
	</analytic>
	<monogr>
		<title level="j">Urol Int</title>
		<imprint>
			<biblScope unit="volume">81</biblScope>
			<biblScope unit="issue">4</biblScope>
			<biblScope unit="page" from="383" to="388" />
			<date type="published" when="2008" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b33">
	<analytic>
		<title level="a" type="main">Development of a patient decision aid for the treatment of localised prostate cancer: A participatory design approach</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">H</forename><forename type="middle">H</forename><surname>Al-Itejawi</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">C</forename><forename type="middle">F</forename><surname>Van Uden-Kraan</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">A</forename><forename type="middle">N</forename><surname>Vis</surname></persName>
		</author>
		<idno type="DOI">10.1111/jocn.13120</idno>
	</analytic>
	<monogr>
		<title level="j">J Clin Nurs</title>
		<imprint>
			<biblScope unit="volume">25</biblScope>
			<biblScope unit="issue">7</biblScope>
			<biblScope unit="page" from="1131" to="1144" />
			<date type="published" when="2016" />
		</imprint>
	</monogr>
	<note type="report_type">-8 PG-1131-44</note>
</biblStruct>

<biblStruct xml:id="b34">
	<analytic>
		<title level="a" type="main">Effectiveness, costutility and implementation of a decision aid for patients with localised prostate cancer and their partners: Study protocol of a stepped-wedge cluster randomised controlled trial</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Hhm</forename><surname>Al-Itejawi</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">C</forename><forename type="middle">F</forename><surname>Van Uden-Kraan</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">P</forename><forename type="middle">M</forename><surname>Van De Ven</surname></persName>
		</author>
		<idno type="DOI">10.1136/bmjopen-2016-015154</idno>
	</analytic>
	<monogr>
		<title level="j">BMJ Open</title>
		<imprint>
			<biblScope unit="volume">7</biblScope>
			<biblScope unit="issue">9</biblScope>
			<date type="published" when="2017" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b35">
	<analytic>
		<title level="a" type="main">Choice between prostatectomy and radiotherapy when men are eligible for both: A randomized controlled trial of usual care vs decision aid</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><forename type="middle">J</forename><surname>Van Tol-Geerdink</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Willem</forename><surname>Leer</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><surname>Weijerman</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">P</forename><forename type="middle">C</forename></persName>
		</author>
		<idno type="DOI">10.1111/j.1464-410X.2012.11402.x</idno>
	</analytic>
	<monogr>
		<title level="j">BJU Int</title>
		<imprint>
			<biblScope unit="volume">111</biblScope>
			<biblScope unit="issue">4</biblScope>
			<biblScope unit="page" from="564" to="573" />
			<date type="published" when="2013" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b36">
	<analytic>
		<title level="a" type="main">Does a decision aid for prostate cancer affect different aspects of decisional regret, assessed with new regret scales? A randomized, controlled trial</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><forename type="middle">J</forename><surname>Van Tol-Geerdink</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><forename type="middle">W</forename><surname>Leer</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">C</forename><forename type="middle">J</forename><surname>Wijburg</surname></persName>
		</author>
		<idno type="DOI">10.1111/hex.12369</idno>
	</analytic>
	<monogr>
		<title level="j">Heal Expect</title>
		<imprint>
			<biblScope unit="volume">19</biblScope>
			<biblScope unit="issue">2</biblScope>
			<date type="published" when="2016" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b37">
	<analytic>
		<title level="a" type="main">Evidence-based patient choice: A prostate cancer decision aid in plain language</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><surname>Holmes-Rovner</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">S</forename><surname>Stableford</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">A</forename><surname>Fagerlin</surname></persName>
		</author>
		<idno type="DOI">10.1186/1472-6947-5-16</idno>
	</analytic>
	<monogr>
		<title level="j">BMC Med Inform Decis Mak</title>
		<imprint>
			<biblScope unit="volume">5</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page">16</biblScope>
			<date type="published" when="2005" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b38">
	<analytic>
		<title level="a" type="main">Decision aids for benign prostatic hyperplasia and prostate cancer</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">D</forename><surname>Arterburn</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">R</forename><surname>Wellman</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">E</forename><forename type="middle">O</forename><surname>Westbrook</surname></persName>
		</author>
		<idno>PG-e130- 40):e130-40. NS -</idno>
	</analytic>
	<monogr>
		<title level="j">Am J Manag Care</title>
		<imprint>
			<biblScope unit="volume">21</biblScope>
			<biblScope unit="issue">2</biblScope>
			<date type="published" when="2015" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b39">
	<analytic>
		<title level="a" type="main">Impact of a decision aid on newly diagnosed prostate cancer patients&apos; understanding of the rationale for active surveillance</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><forename type="middle">K</forename><surname>Formica</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">S</forename><surname>Wason</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><forename type="middle">D</forename><surname>Seigne</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">T</forename><forename type="middle">M</forename><surname>Stewart</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.pec.2016.11.019</idno>
	</analytic>
	<monogr>
		<title level="j">Patient Educ Couns</title>
		<imprint>
			<biblScope unit="volume">100</biblScope>
			<biblScope unit="issue">5</biblScope>
			<biblScope unit="page" from="812" to="817" />
			<date type="published" when="2017" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b40">
	<analytic>
		<title level="a" type="main">The impact of explicit values clarification exercises in a patient decision aid emerges after the decision is actually made: Evidence from a randomized controlled trial</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">D</forename><surname>Feldman-Stewart</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">C</forename><surname>Tong</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">R</forename><surname>Siemens</surname></persName>
		</author>
		<idno type="DOI">10.1177/0272989x11434601</idno>
	</analytic>
	<monogr>
		<title level="j">Med Decis Mak</title>
		<imprint>
			<biblScope unit="volume">32</biblScope>
			<biblScope unit="page" from="616" to="626" />
			<date type="published" when="2012" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b41">
	<analytic>
		<title level="a" type="main">The Personal Patient Profile-Prostate decision support for men with localized prostate cancer: A multi-center randomized trial</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">D</forename><forename type="middle">L</forename><surname>Berry</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">B</forename><surname>Halpenny</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">F</forename><surname>Hong</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.molcel.2009.10.020.The</idno>
	</analytic>
	<monogr>
		<title level="j">Urol Oncol Semin Orig Investig</title>
		<imprint>
			<biblScope unit="volume">31</biblScope>
			<biblScope unit="issue">7</biblScope>
			<biblScope unit="page" from="1012" to="1021" />
			<date type="published" when="2013" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b42">
	<analytic>
		<title level="a" type="main">Decision support with the personal patient profile-prostate: A multicenter randomized trial</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">D</forename><forename type="middle">L</forename><surname>Berry</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">F</forename><surname>Hong</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">T</forename><forename type="middle">M</forename><surname>Blonquist</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.juro.2017.07.076</idno>
	</analytic>
	<monogr>
		<title level="j">J Urol</title>
		<imprint>
			<biblScope unit="volume">199</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="89" to="97" />
			<date type="published" when="2018" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b43">
	<analytic>
		<title level="a" type="main">Impact of a web-based treatment decision aid for early-stage prostate cancer on shared decision-making and health outcomes: Study protocol for a randomized controlled trial</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><surname>Cuypers</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">R</forename><forename type="middle">E</forename><surname>Lamers</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">P</forename><forename type="middle">J</forename><surname>Kil</surname></persName>
		</author>
		<idno type="DOI">10.1186/s13063-015-0750-x</idno>
	</analytic>
	<monogr>
		<title level="j">Trials</title>
		<imprint>
			<biblScope unit="volume">16</biblScope>
			<biblScope unit="page">231</biblScope>
			<date type="published" when="2015" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b44">
	<analytic>
		<title level="a" type="main">How do patients choose between active surveillance, radical prostatectomy, and radiotherapy? The effect of a preference-sensitive decision aid on treatment decision making for localized prostate cancer</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Red</forename><surname>Lamers</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><surname>Cuypers</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">De</forename><surname>Vries</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><surname>Van De Poll-Franse</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">L V</forename><surname>Bosch</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Jlhr</forename><surname>Kil</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Pjm</forename></persName>
		</author>
		<idno type="DOI">10.1016/j.urolonc.2016.09.007</idno>
	</analytic>
	<monogr>
		<title level="j">Urol Oncol Semin Orig Investig</title>
		<imprint>
			<biblScope unit="volume">35</biblScope>
			<biblScope unit="issue">37</biblScope>
			<biblScope unit="page" from="9" to="37" />
			<date type="published" when="2017" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b45">
	<analytic>
		<title level="a" type="main">Examining the impact of a multimedia intervention on treatment decision making among newly diagnosed prostate cancer patients: Results from a nationwide RCT</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><forename type="middle">A</forename><surname>Diefenbach</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">C</forename><surname>Benedict</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Smh</forename><surname>Miller</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Transl Behav Med</title>
		<imprint>
			<date type="published" when="2018" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b46">
	<analytic>
		<title level="a" type="main">How do patients between the age of 65 and 75 use a web-based decision aid for treatment choice in localized prostate cancer?</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><surname>Schrijvers</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><surname>Vanderhaegen</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">H</forename><surname>Van Poppel</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">K</forename><surname>Haustermans</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">C</forename><surname>Van Audenhove</surname></persName>
		</author>
		<idno type="DOI">10.1111/jebm.12051</idno>
	</analytic>
	<monogr>
		<title level="j">J Evid Based Med</title>
		<imprint>
			<biblScope unit="volume">6</biblScope>
			<biblScope unit="issue">3</biblScope>
			<biblScope unit="page" from="167" to="172" />
			<date type="published" when="2013" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b47">
	<analytic>
		<title level="a" type="main">Simple tools for understanding risks: From innumeracy to insight</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">G</forename><surname>Gigerenzer</surname></persName>
		</author>
		<idno type="DOI">10.1136/bmj.327.7417.741</idno>
	</analytic>
	<monogr>
		<title level="j">Bmj</title>
		<imprint>
			<biblScope unit="volume">327</biblScope>
			<biblScope unit="issue">7417</biblScope>
			<biblScope unit="page" from="741" to="744" />
			<date type="published" when="2003" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b48">
	<monogr>
		<title level="m" type="main">Visualizing uncertainty about the future. Science (80-)</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">D</forename><surname>Spiegelhalter</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><surname>Pearson</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">I</forename><surname>Short</surname></persName>
		</author>
		<idno type="DOI">10.1126/science.1191181</idno>
		<imprint>
			<date type="published" when="2011" />
			<biblScope unit="volume">333</biblScope>
			<biblScope unit="page" from="1393" to="1400" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b49">
	<analytic>
		<title level="a" type="main">Who profits from visual aids: Overcoming challenges in people&apos;s understanding of risks</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">R</forename><surname>Garcia-Retamero</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><surname>Galesic</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.socscimed.2009.11.031</idno>
	</analytic>
	<monogr>
		<title level="j">Soc Sci Med</title>
		<imprint>
			<biblScope unit="volume">70</biblScope>
			<biblScope unit="issue">7</biblScope>
			<biblScope unit="page" from="1019" to="1025" />
			<date type="published" when="2010" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b50">
	<analytic>
		<title level="a" type="main">A behavior change model for internet interventions</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">L</forename><forename type="middle">M</forename><surname>Ritterband</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">F</forename><forename type="middle">P</forename><surname>Thorndike</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">D</forename><forename type="middle">J</forename><surname>Cox</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">B</forename><forename type="middle">P</forename><surname>Kovatchev</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">L</forename><forename type="middle">A</forename><surname>Gonder-Frederick</surname></persName>
		</author>
		<idno type="DOI">10.1007/s12160-009-9133-4</idno>
	</analytic>
	<monogr>
		<title level="j">Ann Behav Med</title>
		<imprint>
			<biblScope unit="volume">38</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="18" to="27" />
			<date type="published" when="2009" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b51">
	<analytic>
		<title level="a" type="main">The accuracy of patients&apos; perceptions of the risks associated with localised prostate cancer treatments</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M-A</forename><surname>Van Stam</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">H</forename><forename type="middle">G</forename><surname>Van Der Poel</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Jrn</forename><surname>Van Der Voort Van Zyp</surname></persName>
		</author>
		<idno type="DOI">10.1111/bju.14034</idno>
	</analytic>
	<monogr>
		<title level="j">BJU Int</title>
		<imprint>
			<date type="published" when="2017" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b52">
	<analytic>
		<title level="a" type="main">The new standard: Personalised information about the risks and benefits of treatment strategies for localised prostate cancer</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><forename type="middle">A</forename><surname>Van Stam</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">H</forename><surname>Van Der Poel</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.eururo.2018.03.018</idno>
	</analytic>
	<monogr>
		<title level="j">Eur Urol</title>
		<imprint>
			<biblScope unit="volume">74</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="34" to="36" />
			<date type="published" when="2018" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b53">
	<analytic>
		<title level="a" type="main">Cognitive biases associated with medical decisions: A systematic review</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">G</forename><surname>Saposnik</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">D</forename><surname>Redelmeier</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">C</forename><forename type="middle">C</forename><surname>Ruff</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">P</forename><forename type="middle">N</forename><surname>Tobler</surname></persName>
		</author>
		<idno type="DOI">10.1186/s12911-016-0377-1</idno>
	</analytic>
	<monogr>
		<title level="j">BMC Med Inform Decis Mak</title>
		<imprint>
			<biblScope unit="volume">16</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="1" to="14" />
			<date type="published" when="2016" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b54">
	<monogr>
		<title level="m" type="main">Communicating prognosis to patients with metastatic disease: What do they really want to know? Support Care Cancer</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">P</forename><surname>Butow</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">S</forename><surname>Dowsett</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">R</forename><surname>Hagerty</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><surname>Tattersall</surname></persName>
		</author>
		<idno type="DOI">10.1007/s005200100290</idno>
		<imprint>
			<date type="published" when="2002" />
			<biblScope unit="volume">10</biblScope>
			<biblScope unit="page" from="161" to="168" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b55">
	<analytic>
		<title level="a" type="main">Shared decision making: Really putting patients at the centre of healthcare</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">A</forename><forename type="middle">M</forename><surname>Stiggelbout</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Mptd</forename><surname>Wit</surname></persName>
		</author>
		<idno type="DOI">10.1136/bmj.e256</idno>
	</analytic>
	<monogr>
		<title level="j">Bmj</title>
		<imprint>
			<biblScope unit="volume">344</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="256" to="256" />
			<date type="published" when="2012" />
		</imprint>
	</monogr>
</biblStruct>

				</listBibl>
			</div>
		</back>
	</text>
</TEI>
